Multi-omics Model Predicts Efficacy of Preoperative Neoadjuvant Chemoradiotherapy Combined PD-1 Antibody Therapy for Locally Advanced Rectal Cancer

NCT05368051 · clinicaltrials.gov ↗

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Neoplasms

Interventions

COMBINATION_PRODUCT: long course radiotherapy + capecitabine + PD-1 monoclonal antibody

Sponsor

Beijing Friendship Hospital